Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Endocrine 1

Conditions

Breast Neoplasms 5Pain, Postoperative 4Prostatic Neoplasms 3Postoperative Hemorrhage 2Neoplasms 2Kidney Neoplasms 2Delirium 2Central Nervous System Diseases 2Brain Neoplasms 2Thyroid Neoplasms 1Thromboembolism 1Surgical Wound Infection 1Spondylitis, Ankylosing 1Sleep Deprivation 1Skin Neoplasms 1Skin Diseases 1Seroma 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Postoperative Shivering 1Pleural Effusion, Malignant 1Pituitary Neoplasms 1Pituitary Diseases 1Ovarian Neoplasms 1Neuroinflammatory Diseases 1Neurocognitive Disorders 1Neoplasms, Fibrous Tissue 1Neoplasms, Connective and Soft Tissue 1Neoplasms, Connective Tissue 1Neoplasms by Site 1Neoplasms by Histologic Type 1

Interventions

Dexmedetomidine 3Cabergoline 3pegvisomant 1pasireotide 1lanreotide 1Trimethoprim 1Sulfamethoxazole 1Sodium Chloride 1Sevoflurane 1Saline Solution 1Propofol 1Prednisone 1Octreotide 1Ibuprofen 1Hydrocortisone 1Hormone Replacement Therapy 1Cefdinir 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Pituitary Neoplasms × Sodium Chloride × Clear all
NCT02549768 2016-10-12

Effect of Dexmedetomidine on Plasmatic Cortisol Response in Transsphenoidal Surgery

Pontificia Universidad Catolica de Chile

Phase 4 Unknown
40 enrolled
Endocrine

Pituitary Diseases, Pituitary Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡